PCR systems have made prepared for progression in life sciences investigate and nuclear diagnostics through its most potential components, for instance, incomparable distinguishing proof and estimation of innate materials, for instance, DNA and RNA. Researchers can assess and explore remarkable alleles and point changes using advanced PCR frameworks, for instance, progressed PCR. Makers are possessed with making PCR framework with redesigned capacities, for instance, wide menu of tests, higher affectability and specificity. Other genuine advances related with the PCR fuse shorter turnaround times (PCR cycling time), higher benefit and robotized work process; as needs be ensuring capable area and increase of inherited materials with exact results.
How Big is The Global PCR Devices Market?
The Global PCR Devices Market is expected to be around US$ 7.60 Billion by 2028 at a CAGR of 9% in the given forecast period.
The major driving factors of Global PCR Devices Market are as follows:
The restraining factors of Global PCR Devices Market are as follows:
The Global PCR Devices Market is segmented on the lines of its technology, treatment, application and regional. Based on technology segmentation it covers Quantitative PCR (qPCR) and Digital PCR (dPCR). On product segmentation it covers Quantitative PCR (qPCR) it includes Instruments, Reagents and Consumables, Software and Services where as in Digital PCR (dPCR) Includes Instruments, Reagents and Consumables, Software and Services. On application basis it covers Quantitative PCR (qPCR), it includes Clinical applications, Research application and Forensic application in Digital PCR (dPCR) includes Clinical applications, Research application and Forensic application. On the segmentation of end users it covers Quantitative PCR (qPCR) which includes Research Laboratories and Academic Institutes, Pharma and Biotech Companies, Hospitals and Diagnostic Centers, Clinical Research Organizations and Forensic Laboratories where as Digital PCR (dPCR) includes Academic Institutes, Pharma and Biotech Companies, Hospitals and Diagnostic Centers, Clinical Research Organizations and Forensic Laboratories. The Global PCR Devices Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the global market for PCR Devices Market and related technologies.
2) Analyses of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2028.
3) Identifications of new market opportunities and targeted promotional plans for PCR Devices Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
Report scope:
The scope of the report includes a detailed study of global and regional markets on PCR Devices Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include PCR (qPCR) market include Bio-Rad Laboratories Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), Danaher Corporation (U.S.), Takara Bio Inc. (Japan),Thermo Fisher Scientific Inc. (U.S.), bioMérieux S.A. (France), Fluidigm Corporation (U.S.), Abbot Laboratories (U.S.), and Agilent Technologies, Inc. (U.S.). Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
The Global PCR Devices Market has been segmented as below:
By Technology Analysis:
By Product Analysis:
By Application Analysis
By End User Analysis:
By Regional Analysis:
Reasons to Buy this Report:
1) Obtain the most up to date information available on all Global PCR Devices Market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Global PCR Devices Market data.
4) Assess your competitor’s refining portfolio and its evolution.
Customization:
We can offer you custom research reports as per client’s special requirements.
1 INTRODUCTION
1.1 Key Take Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Breakdown of Primaries
2.2 Factor Analysis
2.2.1 Introduction
2.2.2 Demand-Side Analysis
2.2.2.1 Healthcare Expenditure Patterns
2.2.2.2 Rapid Growth of Aging Population
2.2.2.3 Incidence and Prevalence of Cancer
2.2.2.4 Birth Rate/Pregnancies
2.2.2.5 Burden of Infectious Diseases
2.2.2.6 Number of Clinical, Forensics, and Research Laboratories
2.2.3 Supply-Side Analysis
2.2.3.1 Number of Product Launches: qPCR and dPCR vs Competitive Technologies
2.2.3.2 Parent Market Analysis: Polymerase Chain Reaction (PCR) Market
2.3 Market Size Estimation
2.3.1 Top-Down Approach
2.3.2 Bottom-Up Approach
2.3.2.1 Bottom-Up Approach: dPCR and qPCR Instruments and Software
2.3.2.2 Bottom-Up Approach: dPCR and qPCR Reagents
2.4 Data Triangulation
2.5 Research Assumptions
3 Executive Summary
3.1 Introduction
3.2 Conclusion
4 Premium Insights
4.1 dPCR and qPCR Market Overview (2019-2024)
4.2 Global qPCR and dPCR Technology Market, By Region 2019 Vs.2024 (USD Million)
4.3 Global qPCR and dPCR Market Share, By Product and Service (2018)
4.4 Regional Analyiss: qPCR Market, By Application, 2018 vs 2024 (USD Million)
4.5 Regional Analysis: dPCR Market, By Application, 2018 vs 2024 (USD Million)
5 Market Overview
5.1 Introduction
5.2 Technological Evolution in qPCR/dPCR
5.3 Market Dynamics
5.3.1 Major Market Drivers
5.3.1.1 Rising Incidences of Infectious Diseases and Genetic Disorders
5.3.1.2 Technological Advancement in PCR Technologies
5.3.1.3 Increasing Public-Private Investments, Funds, and Grants
5.3.1.4 Increasing Use of Biomarker Profiling for Disease Diagnostics
5.3.1.5 Successful Completion of the Human Genome Project
5.3.2 Major Market Restraints
5.3.2.1 High Device Costs Associated With dPCR
5.3.2.2 Technical Limitations of qPCR and dPCR Techniques
5.3.3 Major Market Opportunities
5.3.3.1 Growing Market Penetration in Emerging Countries
5.3.3.2 Shift From Plant-Derived to Genome-Based Drug Discovery
5.3.4 Major Market Challenges
5.3.4.1 Adoption and Implementation of Miqe Guidelines for Publishing qPCR and dPCR-Based Research
6 Industry Trends
6.1 Introduction
6.2 Value Chain Analysis
6.3 Industry Trends
6.3.1 Development of Lab-On-Chip PCR Devices
6.3.2 Ongoing Technological Integration With PCR Process
6.4 Porter’s Five Forces Analysis
6.4.1 qPCR Market: Porter’s Five Forces Analysis
6.4.2 dPCR Market: Porter’s Five Forces Analysis
7 Global qPCR and dPCR Market, By Technology
7.1 Introduction
7.2 Quantitative PCR (qPCR)
7.3 Digital PCR (dPCR)
8 Global qPCR and dPCR Market, By Product and Service
8.1 Introduction
8.2 qPCR Products and Services
8.2.1 qPCR Reagents and Consumables
8.2.2 qPCR Instruments
8.2.3 qPCR Software and Services
8.3 dPCR Products and Services
8.3.1 dPCR Instruments
8.3.2 dPCR Reagents and Consumables
8.3.3 dPCR Software and Services
9 qPCR and dPCR Market, By Application
9.1 Introduction
9.2 qPCR Applications
9.2.1 Clinical Applications
9.2.1.1 Pathogen Testing
9.2.1.2 Oncology Testing
9.2.1.3 Blood Screening
9.2.1.4 Other Clinical Applications
9.2.2 Research Applications
9.2.3 Forensic Applications
9.3 dPCR Applications
9.3.1 Clinical Applications
9.3.1.1 Pathogen Testing
9.3.1.2 Oncology Testing
9.3.1.3 Blood Screening
9.3.1.4 Other Clinical Applications
9.3.2 Research Applications
9.3.3 Forensic Applications
10 qPCR and dPCR Market, By End User
10.1 Introduction
10.2 Quantitative PCR (qPCR) End Users
10.2.1 Hospitals and Diagnostic Centers
10.2.2 Research Laboratories and Academic Institutes
10.2.3 Pharmaceutical and Biotechnology Companies
10.2.4 Clinical Research Organizations
10.2.5 Forensic Laboratories
10.3 Digital PCR (dPCR) End Users
10.3.1 Research Laboratories and Academic Institutes
10.3.2 Hospitals and Diagnostic Centers
10.3.3 Pharmaceutical and Biotechnology Companies
10.3.4 Clinical Research Organizations
10.3.5 Forensic Laboratories
11 qPCR and dPCR Market, By Region
11.1 Introduction
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 U.K.
11.3.3 France
11.3.4 Rest of Europe
11.4 Asia-Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Rest of APAC (RoAPAC)
11.5 Rest of the World (RoW)
12 Competitive Landscape
12.1 Overview
12.2 Vendor Inclusion Criteria
12.3 Competitive Leadership Mapping
12.3.1 Visionary Leaders
12.3.2 Innovators
12.3.3 Dynamic Differentiators
12.3.4 Emerging Companies
12.4 Competitve Benchmarking
12.4.1 Analysis of Product Portfolio of Major Players in the dPCR and qPCR Market (25 Players)
12.4.2 Business Strategies Adopted By Major Players in the dPCR and qPCR Market (25 Players)
12.5 Market Share Analysis
12.5.1 qPCR Market Share Analysis (2018)
12.5.2 dPCR Market Share Analysis (2018)
13 Company Profiles
(Overview, Products and Services, Financials, Strategy & Development)*
13.1 Introduction
13.2 F. Hoffman-La Roche Ltd.
13.3 Thermo Fisher Scientific, Inc.
13.4 Bio-Rad Laboratories, Inc.
13.5 Qiagen N.V.
13.6 Takara Bio, Inc.
13.7 Agilent Technologies, Inc.
13.8 Biomérieux S.A.
13.9 Fluidigm Corporation
13.10 Danaher Corporation
13.11 ABBott Laboratories
13.12 Merck KGaA
13.13 Becton Dickinson and Company
13.14 Promega Corporation
13.15 Meridian Bioscience, Inc. (Bioline Reagents Ltd.)
13.16 Analytik Jena AG (Endress+Hauser Ag)
The Global PCR Devices Market has been segmented as below:
By Technology Analysis:
By Product Analysis:
By Application Analysis
By End User Analysis:
By Regional Analysis:
SUBSCRIBE TO OUR NEWSLETTERS
